Related Experiment Video

Updated: Aug 1, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

[Lowering cholesterol 1998. Cholesterol synthesis inhibitors compared]

K M Kostner1, G M Kostner

  • 1Abteilung für Kardiologie, Innere Medizin II, Universität Wien. kkostner@mail.kard.akh-wien.ac.at

Wiener Klinische Wochenschrift
|November 17, 1998
PubMed

Insights

Statins effectively reduce coronary heart disease mortality by up to 30% and lower LDL-cholesterol by over 50%. Cost-effectiveness is highest in high-risk patients, with six statins offering varied pharmacological profiles.

Area of Science:

  • Cardiovascular Pharmacology
  • Lipid Metabolism
  • Clinical Therapeutics

Context:

  • Large-scale trials demonstrate statins reduce coronary heart disease (CHD) mortality by up to 30%.
  • Pharmacological LDL-cholesterol reduction exceeding 50% is now achievable, previously only by LDL-apheresis.
  • Cost-effectiveness of lipid-lowering therapy varies significantly with patient coronary risk.

Purpose:

  • To analyze the pharmacological and clinical differences among the six available statins.
  • To highlight the varying capacities of statins in reducing LDL-cholesterol, triglycerides, and potential drug interactions.
  • To discuss the optimal application of statins based on patient risk and cost-effectiveness.

Summary:

  • Statins are effective lipid-reducing therapies that significantly decrease CHD mortality.
  • Current statins achieve substantial LDL-cholesterol reduction, primarily via LDL-receptor induction in the liver.
  • Pharmacological differences exist among statins, influencing their efficacy in triglyceride reduction and drug interactions.

Impact:

  • Provides a comprehensive overview of statin pharmacology and clinical actions for healthcare professionals.
  • Informs treatment decisions by detailing cost-effectiveness based on patient coronary risk.
  • Contributes to optimizing lipid-lowering strategies for cardiovascular disease prevention.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Concept Videos

Lipid Digestion01:06

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...